French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence

French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence

The aim of this observational study is to evaluate the utilization in the clinical practice, effectiveness, explantation and re-intervention rate, complications and adverse events of InterStim system in patients indicated to Sacral Neuromodulation therapy for fecal incontinence.

This study will provide additional data about safety and effectiveness of the usage of InterStim system in fecal incontinence environment and at the same time will confirm that results from clinical trials can be transposed to clinical practice.

Inclusion Criteria:

• Patient willing to sign the Data Release Form stating the non opposition to the study conduct;
• Patient able to understand information given by the investigator in terms of data collection and publication;
• At least 18 years old or older.
• Patient indicated to sacral neuromodulation testing with InterStim® system.

Exclusion Criteria:

• Replacement of an existing sacral neuromodulation system (implanted before inclusion period) without any evidence of benefits during a testing period.
• Patient unwilling to comply to data collection and publication rules.